COSTA MESA — Urohealth Systems Inc. said Wednesday that recent acquisitions helped boost sales by 30% for the fiscal first quarter, but the company also posted higher losses.
The Costa Mesa maker and marketer of treatments for impotence and incontinence posted sales of $6.2 million in the three months ended Sept. 30, up from $4.8 million in the same period last year.
The company, previously named Davstar Industries Inc., posted a loss of $2.7 million, or 14 cents a share, compared with $2 million, or 11 cents a share, last year. The recent loss included a charge of $1.1 million, or 5 cents a share, for acquisition expenses.
Thomas Gunderson, an analyst at Piper, Jaffray & Hopwood Inc. in Minneapolis, said analysts now care more about Urohealth's sales growth than its losses. Assuming the company can continue boosting sales, he said, profits should follow.